These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
344 related articles for article (PubMed ID: 8483621)
1. How common is whooping cough in a nonvaccinating country? Isacson J; Trollfors B; Taranger J; Zackrisson G; Lagergård T Pediatr Infect Dis J; 1993 Apr; 12(4):284-8. PubMed ID: 8483621 [TBL] [Abstract][Full Text] [Related]
2. History of whooping cough in nonvaccinated Swedish children, related to serum antibodies to pertussis toxin and filamentous hemagglutinin. Zackrisson G; Taranger J; Trollfors B J Pediatr; 1990 Feb; 116(2):190-4. PubMed ID: 2299488 [TBL] [Abstract][Full Text] [Related]
3. Serum antibodies against a 69-kilodalton outer-membrane protein, pertactin, from Bordetella pertussis in nonvaccinated children with and without a history of clinical pertussis. Trollfors B; Zackrisson G; Taranger J; Lagergård T J Pediatr; 1992 Jun; 120(6):924-6. PubMed ID: 1593352 [TBL] [Abstract][Full Text] [Related]
4. Sustained efficacy during the first 6 years of life of 3-component acellular pertussis vaccines administered in infancy: the Italian experience. Salmaso S; Mastrantonio P; Tozzi AE; Stefanelli P; Anemona A; Ciofi degli Atti ML; Giammanco A; Pediatrics; 2001 Nov; 108(5):E81. PubMed ID: 11694665 [TBL] [Abstract][Full Text] [Related]
5. Immunologic and epidemiologic experience of vaccination with a monocomponent pertussis toxoid vaccine. Taranger J; Trollfors B; Bergfors E; Knutsson N; Lagergård T; Schneerson R; Robbins JB Pediatrics; 2001 Dec; 108(6):E115. PubMed ID: 11731642 [TBL] [Abstract][Full Text] [Related]
6. Antibody responses after vaccination and disease against leukocytosis promoting factor, filamentous hemagglutinin, lipopolysaccharide and a protein binding to complement-fixing antibodies induced during whooping cough. Winsnes R; Lønnes T; Møgster B; Berdal BP Dev Biol Stand; 1985; 61():353-65. PubMed ID: 2872124 [TBL] [Abstract][Full Text] [Related]
7. Mass vaccination of children with pertussis toxoid--decreased incidence in both vaccinated and nonvaccinated persons. Taranger J; Trollfors B; Bergfors E; Knutsson N; Sundh V; Lagergård T; Lind-Brandberg L; Zackrisson G; White J; Cicirello H; Fusco J; Robbins JB Clin Infect Dis; 2001 Oct; 33(7):1004-10. PubMed ID: 11528572 [TBL] [Abstract][Full Text] [Related]
8. Acquisition of IgG serum antibodies against two Bordetella antigens (filamentous hemagglutinin and pertactin) in children with no symptoms of pertussis. Isacson J; Trollfors B; Taranger J; Lagergård T Pediatr Infect Dis J; 1995 Jun; 14(6):517-21. PubMed ID: 7667057 [TBL] [Abstract][Full Text] [Related]
10. Estimating incidence of whooping cough over time: a cross-sectional recall study of four Swedish birth cohorts. Krantz I; Taranger J; Trollfors B Int J Epidemiol; 1989 Dec; 18(4):959-63. PubMed ID: 2621033 [TBL] [Abstract][Full Text] [Related]
11. Pertussis seroepidemiology in women and their infants in Sarlahi District, Nepal. Hughes MM; Englund JA; Edwards K; Yoder S; Tielsch JM; Steinhoff M; Khatry SK; LeClerq SC; Katz J Vaccine; 2017 Dec; 35(48 Pt B):6766-6773. PubMed ID: 29037576 [TBL] [Abstract][Full Text] [Related]
12. A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children. Pichichero ME; Deloria MA; Rennels MB; Anderson EL; Edwards KM; Decker MD; Englund JA; Steinhoff MC; Deforest A; Meade BD Pediatrics; 1997 Nov; 100(5):772-88. PubMed ID: 9346976 [TBL] [Abstract][Full Text] [Related]
13. Impact of infant and preschool pertussis vaccinations on memory B-cell responses in children at 4 years of age. Hendrikx LH; de Rond LG; Oztürk K; Veenhoven RH; Sanders EA; Berbers GA; Buisman AM Vaccine; 2011 Aug; 29(34):5725-30. PubMed ID: 21669247 [TBL] [Abstract][Full Text] [Related]
14. The epidemiological situation of pertussis in the Federal Republic of Germany. Finger H; Wirsing von König CH; Tacken A; Wassilak SG Dev Biol Stand; 1991; 73():343-55. PubMed ID: 1778329 [TBL] [Abstract][Full Text] [Related]
15. A cross-sectional study of Bordetella pertussis seroprevalence and estimated duration of vaccine protection against pertussis in St. Petersburg, Russia. Kurova N; Timofeeva EV; Guiso N; Macina D Vaccine; 2018 Dec; 36(52):7936-7942. PubMed ID: 30448334 [TBL] [Abstract][Full Text] [Related]
16. A National Seroepidemiologic Survey of Pertussis Among School Children in Taiwan. Lu CY; Tsai HC; Huang YC; Huang DT; Liu CC; Huang LM; Pediatr Infect Dis J; 2017 Dec; 36(12):e307-e312. PubMed ID: 28737625 [TBL] [Abstract][Full Text] [Related]
17. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection. Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126 [TBL] [Abstract][Full Text] [Related]
18. [Pertussis seroprevalence and vaccination status in three selected provinces of Turkey]. Kurtoğlu D; Gözalan A; Cöplü N; Miyamura K; Ishida S; Morita M; Akin L; Esen B Mikrobiyol Bul; 2008 Jul; 42(3):389-98. PubMed ID: 18822881 [TBL] [Abstract][Full Text] [Related]
19. [Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough]. Rastawicki W; Smietańska K; Rokosz-Chudziak N; Jagielski M Med Dosw Mikrobiol; 2013; 65(4):269-74. PubMed ID: 24730215 [TBL] [Abstract][Full Text] [Related]
20. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis. Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]